Morgan Stanley analyst Shoji Sato downgraded Ibiden (IBIDF) to Equal Weight from Overweight with a price target of 13,000 yen, up from 9,500 yen. Though the firm expects continued earnings growth, additional upside is likely to be limited given that the stock has already increased 179% since February 28, the analyst tells investors.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBIDF:
- Ibiden Co: Positioned for Growth Amid AI and Semiconductor Industry Expansion
- Major Bank Says Asia Leads in AI Stocks – Which Are the Best to Buy?
- IBIDEN CO. Reports Strong Q2 Earnings Growth
- IBIDEN Announces Stock Split and Dividend Forecast Update
- IBIDEN Introduces Progressive Dividends and Announces Interim Dividend